Tuesday, 19 November 2002
D0283

This presentation is part of : Display Presentations, Section B. Physiology, Biochemistry, Toxicology, and Molecular Biology

Characterization of monoclonal antibodies to elongation factor-1a by peptide mapping

Theresa L. Murphy and Melissa K. Stuart. Kirksville College of Osteopathic Medicine, Department of Microbiology/Immunology, 800 W. Jefferson Street, Kirksville, MO

We generated a panel of monoclonal antibodies (MABs), specific for the enzyme elongation factor-1a (EF-1a), that are capable of inhibiting translation in Sf21 cell lysates. Three of the MABs (5H3, 7D6, and 7G3) preferentially recognize a 55 kD form of EF-1a, while a fourth antibody (MAB 8B7) most avidly binds to a 63 kD form. To determine whether MABs 5H3, 7D6, and 7G3 recognize the same or different epitopes, EF-1a was subjected to peptide mapping and immunoblot analysis. Peptide maps generated with trypsin yielded identical immunoblot patterns whether probed with MAB 5H3, 7D6, or 7G3; the same was true of peptide maps generated with V8 protease. After a 1-h incubation with trypsin, all three antibodies recognized EF-1a peptides ranging in mass from 25.5 to 55 kD; after 18 h, immunoreactive peptides of 49.9, 45.2, and 34.3 kD were still detected. Incubation of EF-1a with V8 protease for 1 h generated immunoreactive peptides ranging in mass from 18.3 to 55 kD; after overnight digestion, EF-1a peptides of 30.2 and 37.8 kD remained. From these limited findings, MABs 5H3, 7D6, and 7G3 appear to recognize EF-1a epitopes that are identical or spatially close together. Some EF-1a fragments recognized by MABs 5H3, 7D6, and 7G3 also contained epitopes reactive with MAB 8B7.

Keywords: translation, monoclonal antibodies

Back to Display Presentations, Section B. Physiology, Biochemistry, Toxicology, and Molecular Biology
Back to Posters
Back to The 2002 ESA Annual Meeting and Exhibition